D
Rhythm Pharmaceuticals, Inc. RYTM
$50.97 $0.731.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 72.61% 47.76% 51.28% 126.41% 175.70%
Total Other Revenue -- -- -- -- --
Total Revenue 72.61% 47.76% 51.28% 126.41% 175.70%
Cost of Revenue 17.14% 58.71% 31.80% 97.54% 214.49%
Gross Profit 81.15% 46.44% 53.85% 130.49% 170.56%
SG&A Expenses 17.78% 16.09% 21.20% 39.57% 23.02%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 26.85% 16.07% 5.67% 159.15% 28.70%
Operating Income 0.02% 0.15% 13.14% -166.29% 1.99%
Income Before Tax -4.69% -0.43% 31.95% -170.36% 2.49%
Income Tax Expenses -145.92% -193.48% -- -- --
Earnings from Continuing Operations -3.98% 1.18% 30.92% -170.94% 2.02%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -3.98% 1.18% 30.92% -170.94% 2.02%
EBIT 0.02% 0.15% 13.14% -166.29% 1.99%
EBITDA -0.06% 0.03% 13.16% -167.85% 1.95%
EPS Basic -3.06% 3.73% 33.02% -155.47% 6.85%
Normalized Basic EPS -0.64% 5.05% 36.57% -154.91% 7.27%
EPS Diluted -3.06% 3.73% 33.02% -155.47% 6.85%
Normalized Diluted EPS -0.64% 5.05% 36.57% -154.91% 7.27%
Average Basic Shares Outstanding 4.03% 5.78% 7.29% 6.06% 5.17%
Average Diluted Shares Outstanding 4.03% 5.78% 7.29% 6.06% 5.17%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings